Bipartisan Legislation Targets Healthcare Innovation
Groundbreaking bipartisan legislation has been reintroduced by Senators Capito and Shaheen that could transform Medicare’s approach to digital therapeutics. The Access to Prescription Digital Therapeutics Act of 2023 aims to…
I’ve been a follower of prescription digital therapeutics for years. I have watched with great sadness as companies have come and gone without getting the traction their products needed to help broad groups of…
Continue Reading
What You Should Know:
– Click Therapeutics, Inc. (“Click”), a leader in the rapidly evolving field of prescription medical treatments, encompassing both prescription digital therapeutics (PDTs) and software-enhanced drug™ therapies has received FDA marketing authorization…
Continue Reading
What You Should Know:
– Dassault Systèmes has announced a strategic investment in Click Therapeutics, a pioneering company in prescription digital therapeutics (PDTs) and software-enhanced (SE) drug therapies. This investment signifies Dassault Systèmes’ commitment to…
Continue Reading
Introduction
PursueCare, a leader in virtual addiction treatment, has relaunched RESET and RESET-O, two FDA-cleared prescription digital therapeutics (PDTs), designed to help individuals struggling with substance use disorder (SUD) and opioid use disorder (OUD). Originally…
PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics for substance use disorder and opioid use disorder.RESET and RESET-O were initially developed and…
Continue Reading
Otsuka Precision Health, a prescription digital therapeutics company, and Amalgam Rx, a holdings company in the pharmaceutical and nutraceutical market, have launched Elevmi, a digital application designed to help caregivers assist family members who…
Continue Reading
Otsuka Precision Health, a prescription digital therapeutics company, and Amalgam Rx, a holdings company in the pharmaceutical and nutraceutical market, have launched Elevmi, a digital application designed to help caregivers assist family members who…
Continue Reading
What You Should Know:
– Click Therapeutics, a leader in prescription digital therapeutics (DTx), announced today the acquisition of key assets from Better Therapeutics.
– Click’s expansion into cardiometabolic disease follows successful DTx development efforts in…
Continue Reading
What You Should Know:
– Better Therapeutics (BTTX), a developer of prescription digital therapeutics (PDT), announced today it is shuttering operations and terminating its employees as they explore strategic alternatives.
– The announcement follows a special…
Continue Reading
